Glyburide‐induced acute haemolysis in a G6PD‐deficient patient with NIDDM

@article{Meloni1996GlyburideinducedAH,
  title={Glyburide‐induced acute haemolysis in a G6PD‐deficient patient with NIDDM},
  author={G F Meloni and Tullio Meloni},
  journal={British Journal of Haematology},
  year={1996},
  volume={92}
}
In a 61‐year‐old man with glucose‐6‐phosphate dehydrogenase (G6PD) deficiency and poorly controlled non‐insulin‐dependent diabetes mellitus, an episode of acute haemolysis occurred after the administration of glyburide (glibenclamide). Erythrocyte fragmentation, with haemoglobin condensation zones next to clear zones, was observed on peripheral blood smears. Since autoimmune haemolysis was excluded on the basis of laboratory data, acute haemolysis was ascribed to G6PD deficiency. 
Glibenclamide-induced acute haemolytic anaemia revealing a G6PD-deficiency.
TLDR
The relationship between glibenclamide and haemolytic crisis and between G6PD-deficiency and diabetes are discussed and the literature is reviewed.
G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications
TLDR
How G6PD testing can be done reconciling safety with cost is discussed, as more countries are moving along the pathway of malaria elimination, that might require mass administration of primaquine.
Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: from one crisis to another.
TLDR
In patients at risk of G6PD deficiency, the possibility of haemolysis should be explored in case of diabetes crisis, and in African patients with KPT2D diabetes, potentially oxidative hypoglycaemic agents should be avoided in the remission phase of the disease.
Glucose-6-phosphate dehydrogenase deficiency.
TLDR
The three-dimensional structure of G6PD shows a classical dinucleotide binding domain and a novel beta + alpha domain involved in dimerization, which indicates that single amino acid substitutions are a major cause of deficiency.
“Role of G6PD enzyme in neonatal jaundice and its effects on RBC indices”
Glucose-6-phosphate dehydrogenase deficiency is the most common clinically significant red blood cell enzyme defects in human biology. This cross sectional study was carried out to observe the G6PD
Is There a Need for Neonatal Screening of Glucose-6-Phosphate Dehydrogenase Deficiency in Canada?
  • A. Leong
  • Medicine
    McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students
  • 2007
TLDR
G6PD deficiency most commonly manifests as either prolonged neonatal jaundice or acute hemolytic anemia, and is implicated in the pathogenesis of a number of common diseases.
Anaemia, a common but often unrecognized risk in diabetic patients: a review.
TLDR
Screening for autoimmune gastritis, pernicious anaemia, Hashimoto's thyroiditis, coeliac disease and Addison's disease is recommended, and screening for rare causes of anaemia should be suspected in young patients or when the classical causes are excluded.
Medications and Glucose-6-Phosphate Dehydrogenase Deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzyme defect and one of the most common genetic disorders worldwide, with an estimated 400 million people worldwide
Red Blood Cell Fragility and Reticulocyte Count In Hemolytic Anemic Patients with and Without G-6PD Enzyme Deficiency
TLDR
It is concluded that, increased hemolysis of RBC with higher reticulocyte count occur in G-6PD deficient hemolytic anemic patients which may be due to membrane defect.
Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis
TLDR
The present review discusses the latest evidence on the importance of inflammasome-mediated inflammation in pigment nephropathy and highlights the potential role of infammasome inhibitors in the prophylaxis and treatment of pigment neophropathy.
...
1
2
...

References

SHOWING 1-10 OF 12 REFERENCES
Aspirin-induced acute haemolytic anaemia in glucose-6-phosphate dehydrogenase-deficient children with systemic arthritis.
TLDR
In a 4-year 7-month-old boy with glucose-6-phosphate dehydrogenase deficiency and systemic arthritis a severe haemolytic anaemia occurred after the administration of acetylsalicylic acid, and the anaemia was ascribed to aspirin.
Hemoglobin A1 in subjects with G-6-PD deficiency during and after hemolytic crises due to favism.
TLDR
A statistically significant decrease in HbA1 was observed in the favic subjects during hemolytic crises compared with their values 4 months later and those of the control group.
Favism and hemolytic anemia in glucose-6-phosphate dehydrogenase-deficient subjects in North Sardinia.
TLDR
The incidence from 1965 to 1979 of acute hemolytic anemia for a total of 948 cases in G-6-PD-deficient subjects due to the ingestion of fresh or dried fava beans or certain drugs and to viral infections was reported.
Glucose-6-phosphate dehydrogenase deficiency.
TLDR
A defect in an enzyme called glucose-6-phosphate dehydrogenase causes red blood cells to break down prematurely, which results in the destruction ofRed blood cells, which carry oxygen from the lungs to tissues throughout the body.
Serum glutamic oxalacetic transaminase, glutamic pyruvic transaminase, gamma-glutamyl transpeptidase and glutamic dehydrogenase levels in favism.
TLDR
A statistically significant increase, above normal, in serum GOT, GLDH and gamma-GT was observed in the favic subjects during the crisis and all the values reverted to normal in the asymptomatic period.
Hemolytic Anemia in Disorders of Red Cell Metabolism
TLDR
The Red Cell Structure, Red Cell Metabolism, and Other Pathways - 1.2.1 The Red Cell structure and Kinetic Properties.
THE PHARMACOLOGICAL BASIS OF THERAPEUTICS
TLDR
The Pharmacological Basis of Therapeutics, by Prof. Louis Goodman and Prof. Alfred Gilman, New York: The Macmillan Company, 1941, p.
G6PD deficiency and diabetes mellitus in northern Sardinian subjects.
Hemolytic Anemia Associated With Sulfonylurea Use: Case Study and Review of Literature
The Pharmacological Basis of Therapeutics, 8th edn, pp. 1484–1487
  • 1990
...
1
2
...